George C. Thomas

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases.

Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: February 26, 2026

Diffusion tensor imaging analysis along the perivascular space suggests impaired glymphatic clearance in Lewy body dementia subtypes.

Diffusion tensor imaging analysis along the perivascular space suggests impaired glymphatic clearance in Lewy body dementia subtypes.

Journal: Alzheimer's research & therapy

Published: November 25, 2025

Evidence for divergent cortical organisation in Parkinson's disease and Lewy Body Dementia.

Evidence for divergent cortical organisation in Parkinson's disease and Lewy Body Dementia.

Journal: Nature communications

Published: July 09, 2025

Quantitative susceptibility mapping reveals differences between subtypes of Lewy body dementia.

Quantitative susceptibility mapping reveals differences between subtypes of Lewy body dementia.

Journal: Brain : a journal of neurology

Published: February 03, 2025

Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes.

Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 27, 2025

Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease.

Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: January 16, 2025

Longitudinal Associations of Magnetic Susceptibility with Clinical Severity in Parkinson's Disease.

Longitudinal Associations of Magnetic Susceptibility with Clinical Severity in Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: September 13, 2023

Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.

Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.

Journal: Nature communications

Published: July 26, 2023

Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson's Disease.

Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson's Disease.

Journal: Current neurology and neuroscience reports

Published: April 12, 2023

Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson's disease.

Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson's disease.

Journal: Brain communications

Published: September 06, 2022

Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease.

Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease.

Journal: Brain : a journal of neurology

Published: August 19, 2020

Sequence of clinical and neurodegeneration events in Parkinson's disease progression.

Sequence of clinical and neurodegeneration events in Parkinson's disease progression.

Journal: Brain : a journal of neurology

Published: June 01, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026